Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2001International Journal of Cardiovascular Interventions

The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

View Full Paper
Ask AI
Bookmark
Share

Authors

Patrick W. SerruysPatrick W. SerruysInterventional / Structural CardiologyPFPim J. de FeyterCardiac ImagingRBRenée BenghoziRoche (Switzerland)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Serruys et al. (2001) studied this question.

synapsesocial.com/papers/6a7da4d5143763190a3c93ffhttps://doi.org/10.1080/14628840127765
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering1984 · 643 citations
  2. 2Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT)1986 · 1,997 citations
  3. 3Letter: Grading of angina pectoris.1976 · 1,615 citations
  4. 4A Multiple Testing Procedure for Clinical Trials1979 · 3,370 citations
  5. 5Effects of Lipid Lowering by Pravastatin on Progression and Regression of Coronary Artery Disease in Symptomatic Men With Normal to Moderately Elevated Serum Cholesterol Levels1995 · 846 citations